Meanwhile, CML cells may release MICA into plasma, leading to NKG2D down-regulation on CD56+ NK cells and subsequent NK cell dysfunction (188). The gene discussed is MICA; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.